Skip to content

Hyperbaric Chamber and Cardiorespiratory Changes

Hyperbaric Oxygen Therapy and Cardiorespiratory Changes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3rp6tz
Enrollment
Unknown
Registered
2016-06-21
Start date
2016-01-06
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammation, infection, cellulitis, Vasculitis, osteomyelitis.

Interventions

Will be part of this study 50 volunteers, 25 randomized to the control group and 25 for intervention. One session that consisted in the, intermittently, ventilation of pure oxygen (100%) in a sealed a
Other

Sponsors

Universidade do Sagrado Coração
Lead Sponsor
Universidade do Sagrado Coração
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adults (regardless gender); respiratory and cardiac stability; medical indication to the application of hyperbaric oxygen therapy.

Exclusion criteria

Exclusion criteria: difficulty in understanding and performing the activities; physical and emotional malaise during the pressurization; chest tube; pregnant; hyperthermia; history of seizures not treated; postoperative of head/neck and thoracic surgeries; spherocytosis carriers; claustrophobia.

Design outcomes

Primary

MeasureTime frame
Increased periferic oxygen saturation at 4%, after therapy, as measured by eTAMUSSINO oximeter in the fifth toe of his right hand. Lowering blood pressure at 6 mmHg, after therapy, as measured by digital sphygmomanometer Medtech.

Secondary

MeasureTime frame
Increased 1 liter of the slow vital capacity measured by Wright spirometer. Increased respiratory pressure of 5 cm H2O, after therapy, as measured by the Medical Commercial manovacuometer.

Countries

Brazil

Contacts

Public ContactBruno Martinelli

Universidade do Sagrado Coração

internetbruno@yahoo.com.br+55(14)21077042

Outcome results

None listed

Source: REBEC (via WHO ICTRP)